MeiraGTx (MGTX) to Release Earnings on Monday

MeiraGTx (NASDAQ:MGTX) is expected to post its Q2 2025 quarterly earnings results before the market opens on Monday, August 11th. Analysts expect MeiraGTx to post earnings of ($0.52) per share and revenue of $8.00 million for the quarter.

MeiraGTx (NASDAQ:MGTX) last announced its quarterly earnings results on Tuesday, May 13th. The company reported ($0.51) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.38) by ($0.13). The company had revenue of $1.93 million during the quarter, compared to the consensus estimate of $4.44 million. MeiraGTx had a negative return on equity of 241.05% and a negative net margin of 484.90%. On average, analysts expect MeiraGTx to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

MeiraGTx Trading Up 3.4%

Shares of NASDAQ MGTX opened at $7.88 on Friday. The company has a market cap of $633.24 million, a price-to-earnings ratio of -3.40 and a beta of 1.25. MeiraGTx has a 12-month low of $3.85 and a 12-month high of $8.98. The company has a current ratio of 1.53, a quick ratio of 1.51 and a debt-to-equity ratio of 2.34. The stock’s 50 day simple moving average is $7.32 and its 200 day simple moving average is $6.65.

Analyst Ratings Changes

Several analysts recently issued reports on the company. Chardan Capital cut their price target on MeiraGTx from $38.00 to $35.00 and set a “buy” rating on the stock in a report on Wednesday, May 14th. Wall Street Zen raised MeiraGTx from a “sell” rating to a “hold” rating in a report on Saturday, July 5th.

Insider Activity at MeiraGTx

In other MeiraGTx news, CEO Alexandria Forbes sold 47,500 shares of MeiraGTx stock in a transaction on Tuesday, July 8th. The stock was sold at an average price of $7.97, for a total transaction of $378,575.00. Following the sale, the chief executive officer owned 1,361,483 shares of the company’s stock, valued at $10,851,019.51. The trade was a 3.37% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Richard Giroux sold 24,000 shares of MeiraGTx stock in a transaction on Tuesday, July 22nd. The shares were sold at an average price of $8.52, for a total value of $204,480.00. Following the sale, the chief financial officer directly owned 853,494 shares in the company, valued at $7,271,768.88. The trade was a 2.74% decrease in their position. The disclosure for this sale can be found here. Company insiders own 7.50% of the company’s stock.

Institutional Trading of MeiraGTx

An institutional investor recently bought a new position in MeiraGTx stock. AQR Capital Management LLC bought a new stake in shares of MeiraGTx Holdings PLC (NASDAQ:MGTX) during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund bought 82,118 shares of the company’s stock, valued at approximately $557,000. AQR Capital Management LLC owned approximately 0.10% of MeiraGTx at the end of the most recent reporting period. Institutional investors own 67.48% of the company’s stock.

MeiraGTx Company Profile

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.